Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience.

By Anne W. M. Lee, W. Sze, J. Au, S. Leung, T. Leung, D. Chua, B. Zee, S. Law, P. Teo, S. Tung and 2 more. International Journal of Radiation Oncology, Biology, Physics, 2005

603 citations recorded by the source corpus.

Subfields: Otorhinolaryngology, Surgery

View Paper: https://www.semanticscholar.org/paper/884b8a903340c924478a87f38d015f840cd306b2

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Allen Chan
2. A. Chan
3. J. Woo
4. A. King
5. B. Ma
6. Anne W. M. Lee
7. B. Zee
8. W. Ng

Citations in the corpus

• Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective. (2015, background): “With almost half of all patients presenting at an advanced stage, of whom one third subsequently die as a result of this cancer within 5 years of diagnosis, the treatment of stage III to IVB NPC has deservedly been the main focus of clinical research in the past decades.(34) The improvement of clini”
• Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer (2017, positive): “Panel B shows the rate of progression-free survival among the participants as compared with 1278 age- and sex-matched patients in a historical cohort in Hong Kong, which is a subgroup of the study cohort described by Lee et al.20 CI denotes confidence interval.”